X, W., D, L., JW, T., S, S., J, G., X, F., . . . C, A. (2026). Oncolytic adenoviral infection of chordoma achieves treatment efficacy associated with immunologic response and tumor microenvironmental alteration. Neuro-oncology, 28(6), 1458. https://doi.org/10.1093/neuonc/noag045
Chicago Style (17th ed.) CitationX, Wu, et al. "Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration." Neuro-oncology 28, no. 6 (2026): 1458. https://doi.org/10.1093/neuonc/noag045.
MLA (9th ed.) CitationX, Wu, et al. "Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration." Neuro-oncology, vol. 28, no. 6, 2026, p. 1458, https://doi.org/10.1093/neuonc/noag045.